These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 948260

  • 1. [Therapy of peripheral circulatory disorders using BAY b 7979, demonstrated through Tc-99m muscular clearance].
    Nedjabat T, Ebinger H, Birtel FJ.
    Med Welt; 1976 Aug 20; 27(34):1585-7. PubMed ID: 948260
    [No Abstract] [Full Text] [Related]

  • 2. [Combined drug therapy of arterial circulation disorders].
    Grözinger KH.
    Med Welt; 1980 Jul 04; 31(27):1015-8. PubMed ID: 6903251
    [No Abstract] [Full Text] [Related]

  • 3. [Effective therapy of chronic arterial circulatory disorders with Nico-Padutin forte (author's transl)].
    Vorberg G.
    MMW Munch Med Wochenschr; 1976 Oct 29; 118(44):1429-32. PubMed ID: 825753
    [Abstract] [Full Text] [Related]

  • 4. [Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].
    Licata G, Pinto A, Parrinello G, Salli L, Indovina I.
    Clin Ter; 1985 Mar 31; 112(6):503-13. PubMed ID: 4017475
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of peripheral arterial circulation disorders using Nico-Padutin forte].
    Hammer O.
    ZFA (Stuttgart); 1976 Nov 30; 52(33):1740-3. PubMed ID: 795205
    [No Abstract] [Full Text] [Related]

  • 6. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
    D'Ayala Valva G.
    Recenti Prog Med; 1966 Jun 30; 40(6):XIX-XXXVI. PubMed ID: 6014405
    [No Abstract] [Full Text] [Related]

  • 7. [Evaluation of the combined use of Nico-padutin forte and depot-Padutin in peripheral arterial occlusive disease].
    Hoffmann J.
    Med Welt; 1982 Jul 16; 33(28):1034-7. PubMed ID: 6922390
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A, Licciardello M.
    Clin Ter; 1966 Jul 31; 38(2):121-58. PubMed ID: 5990194
    [No Abstract] [Full Text] [Related]

  • 9. [Research on skin temperature and internal temperature in subjects with obliterating arteriopathy. Action of the association of kallikrein and meso-inositol hexanicotinate].
    Blasi A, Licciardello M.
    Clin Ter; 1966 Oct 15; 39(1):33-8. PubMed ID: 5998855
    [No Abstract] [Full Text] [Related]

  • 10. [Results of physical therapy in peripheral arterial circulatory diseases (author's transl)].
    Krause D, Dittmar K.
    Munch Med Wochenschr; 1973 Oct 05; 115(40):1742-4. PubMed ID: 4801041
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II].
    Feliciotti F, De Carolis G, Mariotti C, Mingolla F.
    Ann Ital Chir; 1983 Oct 05; 55(5):493-7. PubMed ID: 6673630
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S, Spinella G, Sciacchitanto D.
    Angiologia; 1975 Oct 05; 27(1):7-25. PubMed ID: 1111377
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Antihypertensive combination-therapy with inositol nicotinate in essential hypertension].
    Krämer KD, Ghabussi P, Hochrein H.
    Med Welt; 1977 Jul 08; 28(27):1198-1201. PubMed ID: 329049
    [No Abstract] [Full Text] [Related]

  • 20. [Muscular clearance of xenon (Xe-133) as a measure of the effectiveness of Provasan and Bametan for the correction of blood flow in the lower limbs].
    Jonderko G, Szramek-Urbaniak A, Lewandowski J.
    Pol Tyg Lek; 1981 Jan 19; 36(3):103-6. PubMed ID: 6113581
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.